MDA

Hot Off The Wires

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards 12/1/2023

SatixFy Announces Nine Months 2023 Results 11/30/2023

Military Satellite Payloads and Subsystems Market to increase by USD 2.91 … 11/30/2023

MDA ANNOUNCES STRATEGIC EXPANSION IN THE UK 11/21/2023

FDA Grants Orphan Drug Designation to EPI-321, Epic Bio's Novel … 11/16/2023

Lockheed Martin Opens 25,000-Square Foot, $16.5M Missile Defense Lab 11/14/2023

MDA TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES 11/9/2023

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights 11/7/2023

MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active … 11/5/2023

The "Jewish Nobel Prize" Rallies Support for Israel 11/1/2023

New York Blood Center Enterprises Grants Exclusive License to Big Eye Diagnostics … 11/1/2023

MDA COMPLETES ACQUISITION OF SATIXFY DIGITAL PAYLOAD DIVISION 10/31/2023

SatixFy Announces Completion of Strategic $60 Million Transaction with MDA 10/31/2023

Santhera Receives U.S. FDA Approval of AGAMREE® (vamorolone) for the Treatment … 10/27/2023

MDA SELECTS SPACEX TO LAUNCH CHORUS CONSTELLATION 10/25/2023

more news »

Quicklinks